That virus ran into a dead end when nearly everyone was ultimately vaccinated.
BS
Which part of the world had the fewest covid cases and deaths?
Vax rates as low as .27%!
statista.com
US
nytimes.com
Trying to Solve a Covid Mystery: Africa's Low Death Rates
Mar 23, 2022A new W.H.O.-led analysis, not yet peer-reviewed, synthesized surveys from across the continent and found that 65 percent of Africans had been infected by the third quarter of 2021, higher than...
Coronavirus in Africa: Five reasons why Covid-19 has been less ... - BBC
Africa has recorded about 37,000 deaths, compared with roughly 580,000 in the Americas, 230,000 in Europe, and 205,000 in Asia.
 https://news.un.org/en/story/2021/12/1107882
COVID cases surging in Africa at fastest rate this year, but deaths ...
An 83 per cent surge in COVID-19 cases during the past week in Africa, driven by the Delta and Omicron variants, is causing fewer deaths than previous spikes, the World Health Organization...
 https://news.sky.com/story/covid-19-in-africa-why-is-the-death-rate-so-low-12236347
COVID-19 in Africa: Why is the official death rate so low?
Africa, a continent of 1.3 billion people, has seen fewer deaths from COVID-19 than the UK, which has a population about a 20th of the size. Inevitably for such a huge landmass, there are major variations, with South Africa in particular experiencing high rates of infection and death. COVID-19: The Ivermectin African Enigma
Rodrigo Guerrero 1 , Luis Eduardo Bravo 2 3 , Edgar Muñoz 4 , Elvia Karina Grillo Ardila 5 , Esteban Guerrero 6
Affiliations
Free PMC article
Abstract
in English, Spanish
Introduction: The low frequency of cases and deaths from the SARS-CoV-2 COVID-19 virus in some countries of Africa has called our attention about the unusual behavior of this disease. The ivermectin is considered a drug of choice for various parasitic and viral diseases and shown to have in vitro effects against SARS-CoV-2.
Aims: Our study aimed to describe SARS-CoV2 infection and death rates in African countries that participated in an intensive Ivermectin mass campaign carried out to control onchocerciasis and compare them with those of countries that did not participate.
Methods: Data from 19 countries that participated in the World Health Organization (WHO) sponsored African Programme for Onchocerciasis Control (APOC), from 1995 until 2015, were compared with thirty-five (Non-APOC), countries that were not included. Information was obtained from worldometers.info database. Generalized Poisson regression models were used to obtain estimates of the effect of APOC status on cumulative SARS-CoV-2 infection and mortality rates.
Results: After controlling for different factors, including the Human Development Index (HDI), APOC countries (vs. non-APOC), show 28% lower mortality (0.72; 95% CI: 0.67-0.78) and 8% lower rate of infection (0.92; 95% CI: 0.91-0.93) due to COVID-19.
Conclusions: The incidence in mortality rates and number of cases is significantly lower among the APOC countries compared to non-APOC countries. That a mass public health preventive campaign against COVID-19 may have taken place, inadvertently, in some African countries with massive community ivermectin use is an attractive hypothesis. Additional studies are needed to confirm it.
Keywords: COVID-19; Onchocerciasis; albendazole; confounding factors epidemiologic; coronavirus 2; coronavirus infections; elephantiasis; filariasis; ivermectin; life expectancy; onchocerciasis ocular; severe acute respiratory syndrome.
Copyright © 2020 Colombia Medica.
|
